These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 6441144)
1. An in vitro animal model for the study of cereal components toxic in celiac disease. Auricchio S; Cardelli M; De Ritis G; De Vincenzi M; Latte F; Silano V Pediatr Res; 1984 Dec; 18(12):1372-8. PubMed ID: 6441144 [TBL] [Abstract][Full Text] [Related]
2. Prevention by mannan and other sugars of in vitro damage of rat fetal small intestine induced by cereal prolamin peptides toxic for human celiac intestine. Auricchio S; De Ritis G; De Vincenzi M; Latte F; Maiuri L; Pino A; Raia V; Silano V Pediatr Res; 1987 Dec; 22(6):703-7. PubMed ID: 3431955 [TBL] [Abstract][Full Text] [Related]
3. Intestinal mucosa of celiacs in remission is unable to abolish toxicity of gliadin peptides on in vitro developing fetal rat intestine and cultured atrophic celiac mucosa. Cornell HJ; Auricchio RS; De Ritis G; De Vincenzi M; Maiuri L; Raia V; Silano V Pediatr Res; 1988 Aug; 24(2):233-7. PubMed ID: 3186334 [TBL] [Abstract][Full Text] [Related]
4. Toxicity of wheat flour proteins and protein-derived peptides for in vitro developing intestine from rat fetus. De Ritis G; Occorsio P; Auricchio S; Gramenzi F; Morisi G; Silano V Pediatr Res; 1979 Nov; 13(11):1255-61. PubMed ID: 390482 [TBL] [Abstract][Full Text] [Related]
5. Effects of gliadin-derived peptides from bread and durum wheats on small intestine cultures from rat fetus and coeliac children. Auricchio S; De Ritis G; De Vincenzi M; Occorsio P; Silano V Pediatr Res; 1982 Dec; 16(12):1004-10. PubMed ID: 7155669 [TBL] [Abstract][Full Text] [Related]
6. Mannan and oligomers of N-acetylglucosamine protect intestinal mucosa of celiac patients with active disease from in vitro toxicity of gliadin peptides. Auricchio S; De Ritis G; De Vincenzi M; Magazzù G; Maiuri L; Mancini E; Minetti M; Sapora O; Silano V Gastroenterology; 1990 Oct; 99(4):973-8. PubMed ID: 2394351 [TBL] [Abstract][Full Text] [Related]
7. The toxicity of certain cereal proteins in coeliac disease. Cornell HJ; Townley RR Gut; 1974 Nov; 15(11):862-9. PubMed ID: 4455563 [TBL] [Abstract][Full Text] [Related]
8. In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease. de Ritis G; Auricchio S; Jones HW; Lew EJ; Bernardin JE; Kasarda DD Gastroenterology; 1988 Jan; 94(1):41-9. PubMed ID: 3335296 [TBL] [Abstract][Full Text] [Related]
9. Are all gliadins toxic in coeliac disease? An in vitro study of alpha, beta, gamma, and w gliadins. Howdle PD; Ciclitira PJ; Simpson FG; Losowsky MS Scand J Gastroenterol; 1984 Jan; 19(1):41-7. PubMed ID: 6710076 [TBL] [Abstract][Full Text] [Related]
10. Toxicity of cereal protein - derived peptides for in vitro developing intestine from rat fetus. Auricchio S; De Ritis G; De Vincenzi M; Silano V J Am Oil Chem Soc; 1979 Mar; 56(3):168-72. PubMed ID: 536528 [No Abstract] [Full Text] [Related]
11. In vitro pathogenetic studies of coeliac disease. Effects of protein digests on coeliac intestinal biopsy specimens maintained in culture for 48 hours. Jos J; Lenoir G; Ritis G D; Rey J Scand J Gastroenterol; 1975; 10(2):121-8. PubMed ID: 1091964 [TBL] [Abstract][Full Text] [Related]
12. Effects of gliadin peptides B1-B4 in celiac disease. I. Organ culture studies. Stallmach A; Belitz HD; Gellermann B; Schäfer H; Wieser H; Stern M J Pediatr Gastroenterol Nutr; 1987; 6(3):335-40. PubMed ID: 3430242 [TBL] [Abstract][Full Text] [Related]
13. An analysis of cereals that react with serum antibodies in patients with coeliac disease. Troncone R; Auricchio S; De Vincenzi M; Donatiello A; Farris E; Silano V J Pediatr Gastroenterol Nutr; 1987; 6(3):346-50. PubMed ID: 3430243 [TBL] [Abstract][Full Text] [Related]
14. Demonstration of the presence of coeliac-activating gliadin-like epitopes in malted barley. Ellis HJ; Doyle AP; Day P; Wieser H; Ciclitira PJ Int Arch Allergy Immunol; 1994 Jul; 104(3):308-10. PubMed ID: 7518270 [TBL] [Abstract][Full Text] [Related]
15. Intestinal T cell responses to cereal proteins in celiac disease. Kilmartin C; Wieser H; Abuzakouk M; Kelly J; Jackson J; Feighery C Dig Dis Sci; 2006 Jan; 51(1):202-9. PubMed ID: 16416236 [TBL] [Abstract][Full Text] [Related]
16. Enzyme-linked immunosorbent assay for quantitation of cereal proteins toxic in coeliac disease. Friis SU Clin Chim Acta; 1988 Dec; 178(3):261-70. PubMed ID: 3240601 [TBL] [Abstract][Full Text] [Related]
17. Structural specificities and significance for coeliac disease of wheat gliadin peptides able to agglutinate or to prevent agglutination of K562(S) cells. De Vincenzi M; Stammati A; Luchetti R; Silano M; Gasbarrini G; Silano V Toxicology; 1998 May; 127(1-3):97-106. PubMed ID: 9699797 [TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of enzymatically hydrolyzed prolamins from wheat, rye, and barley as references for the immunochemical quantitation of partially hydrolyzed gluten. Gessendorfer B; Koehler P; Wieser H Anal Bioanal Chem; 2009 Nov; 395(6):1721-8. PubMed ID: 19763549 [TBL] [Abstract][Full Text] [Related]
20. [Comparative toxicity of different cereals for subjects intolerant of gluten]. Charbonnier L; Jos J; Mougenot JF; Mossé J Reprod Nutr Dev (1980); 1980; 20(4B):1369-77. PubMed ID: 6818635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]